Abstract
Significance: In July 2020, there was great uncertainty around the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite its vital importance for public health policy, knowledge about the cumulative incidence of past infections was limited by challenges with diagnostic testing and the presence of mild or asymptomatic cases. Within this environment, competing narratives emerged around the prevalence of past SARS-CoV-2 infections, which would have had differing policy implications. To address this, in July 2020 a population-representative household survey collected serum for SARS-CoV-2 antibody detection in Ohio in the United States. This study describes a Bayesian statistical method developed to estimate the population prevalence of past infections accounting for the low positive rate; multiple imperfect diagnostic tests; and nonignorable nonresponse.

This publication has 29 references indexed in Scilit: